ID3 and precursor B-cell acute lymphoblastic leukemia: Patients with high expression of both ID1 and ID3 exhibited significantly worse survival outcomes compared to those with lower or single-gene overexpression (Figure 5C) (p = 0.018), supporting our hypothesis regarding the prognostic relevance of these genes in B-ALL.